ARTICLE INFO

Article Type

Case Report

Authors

Hadipour‎   F. (1)
Hadipour‎   Z. (1)
Mousavi   F. (2)
Bagherizadeh   I. (2)
Shafaghati   Y. ()
Behjati   F. (*)






() ‎“Sarem Cell Research Center (SCRC), Sarem Cell Research Center (SCRC), Medical Genetics Department, ‎Sarem Women’s Hospital” and “Genetic Reaearch Center‎, University of Welfore & Rehabilitation Scienws”, Tehran, Iran
(*) ‎“Sarem Cell Research Center (SCRC), Sarem Cell Research Center (SCRC), Medical Genetics Department, ‎Sarem Women’s Hospital” and “Genetic Reaearch Center‎, University of Welfore & Rehabilitation Scienws”, Tehran, Iran
(1) Sarem Fertility & Infertility Research Center (SAFIR) and Sarem Cell Research Center (SCRC) and Medical ‎Genetics Department‎, Sarem Women’s Hospital, Tehran, Iran
(2) ‎Sarem Cell Research Center (SCRC) and Medical Genetics Department‎, Sarem Women’s Hospital, Tehran, Iran

Correspondence

Address: Sarem Women’s Hospital, Basij Square, Phase 3, Ekbatan Town, Tehran, Iran. Postal Code: 1396956111‎
Phone: ‎+98 (21) 44670888‎
Fax: ‎+98 (21) 44670432‎
f_behjati@uswr.ac.ir

Article History

Received:   March  2, 2016
Accepted:   June 21, 2016
ePublished:   August 15, 2016

ABSTRACT

Information & Methods Considering the clinical importance and the deep impact of Premature Ovarian ‎Failure (POF) on the life of affected people and the important role of genetics in its ‎development, this study was conducted to determine the frequency and type of ‎chromosomal abnormalities in Iranian women referred to Sarem Hospital with ‎premature ovarian failure. Karyotype analysis and its association with phenotype ‎were performed on 13 Iranian women with confirmed premature ovarian failure. ‎The metaphase chromosomes were prepared and analyzed with G-bonding ‎technique and mosaicism of 100 cells from lymphocyte cells was studied. Finally, ‎chromosomal abnormalities were diagnosed in 2 of 13 patients (15.38%) with ‎premature ovarian failure. A patient with chromosomal mosaicism was [42] XX, ‎‎46 / [8] X, 45. The second patient had a translocation between chromosome X and ‎chromosome 9, that was 46, XX, t(X,9)(q22.1;q22,1).‎
Conclusion The overall prevalence of chromosomal abnormalities is 15.38% among patients ‎with premature ovarian failure, which is confirmed by our findings in the ‎chromosomal examination of these women.‎


CITATION LINKS

[1]Coulam, CB. Premature gonadal failure. Fertil Steril. 1982;38(6):645-55.‎
[2]de Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil Steril. 1967;18(4):440-61.‎
[3]Mattison DR, Evans MI, Schwimmer WB, White BJ, Jensen B, Schulman JD. Familial premature ovarian failure. ‎Am J Hum Genet. 1984;36(6):1341-8.‎
[4]Coulam CB, Stringfellow S, Hoefnagel D. Evidence for a genetic factor in the etiology of premature ovarian ‎failure. Fertil Steril. 1983;40(5):693-5.‎
[5]Portnoi MF, Aboura A, Tachdjian G, Bouchard P, Dewailly D, Bourcigaux N, et al. Molecular cytogenetic ‎studies of Xq critical regions in premature ovarian failure patients. Hum Reprod. 2006;21:2329-34.‎
[6]Fassnacht W, Mempel A, Strowitzki T, Vogt PH. Premature ovarian failure (POF) syndrome: Towards the ‎molecular clinical analysis of its genetic complexity. Curr Med Chem. 2006;13(12):1397-410.‎
[7]Gardner HA, McConnon JK, MacKenzie MA. An X;9 translocation, primary amenorrhea, and hypothalamic ‎dysfunction. Am J Med Genet. 1983;14(4):647-56. ‎
[8]Leddet-Chevallier I, Reid RA, Carrel RE, Sparkes RS. Balanced reciprocal (X;9) translocation in a girl with ‎primary amenorrhea. Ann genet. 1981;24(3):162-4.‎
[9]Jones GS, DeMoraes-Ruehsen MA. New syndrome of amenorrhea in association with hypergonadotropism ‎and apparently normal ovarian follicular apparatus. Am J Obstet Gynecol. 1969;104(4):597-600. ‎
[10]Maxson WS, Wentz AC. The gonadotropin resistant ovary syndrome. Semin Reprod Endocr. 1983;1(2):147-‎‎60.‎
[11]Fitch N, De Saint Victor J, Richer CL, Pinsky L, Sitahal S. Premature menopause due to a small deletion in the ‎long arm of the X chromosome: A report of three cases and a review. Am J Obstet Gynecol. 1982;142(8):968-‎‎72.‎
[12]Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. Hypergonadotropichypogonadism in ‎female patients with galactosemia. N Engl J Med. 1981;304(17):994-8.‎
[13]Smith A, Fraser IS, Noel M. Three siblings with premature gonadal failure. Fertil Steril. 1979;32(5):528-30.‎
[14]Baronchelli S, Villa N, Redaelli S, Lissoni S, Saccheri F, Panzeri E, et al. Investigating the role of X chromosome ‎breakpoints in premature ovarian failure. Mol Cytogenet. 2012;5:32. ‎
[15]Jiao X, Qin C, Li J, Qin Y, Gao X, Zhang B, et al. Cytogenetic analysis of 531 Chinese women with premature ‎ovarian failure. Hum Reprod. 2012;27(7):2201-7.‎
[16]Ceylaner G, Altinkaya SO, Mollamahmutoglu L, Ceylaner S. Genetic abnormalities in Turkish women with ‎premature ovarian failure. Int J gynaecol Obstet. 2010;110(2):122-4.‎
[17]Zhang J, Tang YY, Guo YP. A study of hypergonadotropic secondary amenorrhea with cytogenetics. J ‎Chongqing Med Univ. 2003;2:151-152.‎
[18]Castillo S, Lopez F, Tobella L, Salazar S, Daher V. The cytogenetics of premature ovarian failure. Rev Chil ‎Obstet Ginecol. 1992;57(5):341-5. [Spanish]‎
[19]Wu RC, Kuo PL, Lin SJ, Liu CH, Tzeng CC. chromosome mosaicism in patients with recurrent abortion or ‎premature ovarian failure. J Formos Med Assoc. 1993;92(11):953-6.‎